Onconano Medicine
OncoNano Medicine is a biotech company that develops pH-activated compounds that digitalize and exploit the variability of pH in disease.
About Onconano Medicine
OncoNano Medicine is a biotech company that develops nanotechnology-enabled fluorescent probes to help cancer surgeons visualize tumors during surgery, allowing them to excise tumors more precisely. The fluorescent sensor targets the different pH signals, thus making them glow so they are easier to distinguish from normal tissue. OncoNano Medicine is a UTSW spinoff company based in Dallas, Texas.
Company Facts
- Headquarters
- Southlake
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $188,135,995
- Last Funding Type
- series_b
- Last Funding Date
- 2021-10-25
- Website
- onconano.com
Industries & Categories
Alternative Medicine, Biotechnology, Health Care, Nanotechnology
Social Links
Canonical: https://fsome.com/organization/onconano-medicine-43010 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.